AMGEN Inc (NASDAQ: AMGN) on Friday, soared 1.60% from the previous trading day, before settling in for the closing price of $289.90. Within the past 52 weeks, AMGN’s price has moved between $260.68 and $346.85.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 3.42%. The company achieved an average annual earnings per share of 4.95%. With a float of $536.14 million, this company’s outstanding shares have now reached $537.53 million.
Considering the fact that the conglomerate employs 26700 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 60.35%, operating margin of 18.85%, and the pretax margin is 14.43%.
AMGEN Inc (AMGN) Insider Activity
Observing investor behavior towards Drug Manufacturers – General industry stocks is more important than anything else. The insider ownership of AMGEN Inc is 0.26%, while institutional ownership is 78.02%. The most recent insider transaction that took place on May 03 ’24, was worth 662,802. In this transaction SVP & CCO of this company sold 2,117 shares at a rate of $313.09, taking the stock ownership to the 9,883 shares. Before that another transaction happened on Dec 04 ’23, when Company’s SVP & CCO sold 2,096 for $273.03, making the entire transaction worth $572,276. This insider now owns 10,874 shares in total.
AMGEN Inc (AMGN) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 4.95% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.00% during the next five years compared to -0.22% drop over the previous five years of trading.
AMGEN Inc (NASDAQ: AMGN) Trading Performance Indicators
AMGEN Inc (AMGN) is currently performing well based on its current performance indicators. A quick ratio of 0.96 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.98. Likewise, its price to free cash flow for the trailing twelve months is 25.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 7.81, a number that is poised to hit 5.04 in the next quarter and is forecasted to reach 20.72 in one year’s time.
Technical Analysis of AMGEN Inc (AMGN)
Compared to the last year’s volume of 2.48 million, its volume of 3.55 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 30.83%. Additionally, its Average True Range was 7.96.
During the past 100 days, AMGEN Inc’s (AMGN) raw stochastic average was set at 26.61%, which indicates a significant decrease from 36.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 40.24% in the past 14 days, which was higher than the 24.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $316.52, while its 200-day Moving Average is $305.89. Nevertheless, the first resistance level for the watch stands at $297.08 in the near term. At $299.63, the stock is likely to face the second major resistance level. The third major resistance level sits at $303.78. If the price goes on to break the first support level at $290.38, it is likely to go to the next support level at $286.23. Should the price break the second support level, the third support level stands at $283.68.
AMGEN Inc (NASDAQ: AMGN) Key Stats
Market capitalization of the company is 160.85 billion based on 537,533K outstanding shares. Right now, sales total 28,190 M and income totals 6,717 M. The company made 8,503 M in profit during its latest quarter, and 2,830 M in sales during its previous quarter.
